Anti-EXOC3L1 monoclonal antibody

Pre-made anti-EXOC3L1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EXOC3L1/EXOC3L1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2481-Ab-1/ GM-Tg-hg-IP2481-Ab-2Anti-Human EXOC3L1 monoclonal antibodyHuman
GM-Tg-rg-IP2481-Ab-1/ GM-Tg-rg-IP2481-Ab-2Anti-Rat EXOC3L1 monoclonal antibodyRat
GM-Tg-mg-IP2481-Ab-1/ GM-Tg-mg-IP2481-Ab-2Anti-Mouse EXOC3L1 monoclonal antibodyMouse
GM-Tg-cynog-IP2481-Ab-1/ GM-Tg-cynog-IP2481-Ab-2Anti-Cynomolgus/ Rhesus macaque EXOC3L1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2481-Ab-1/ GM-Tg-felg-IP2481-Ab-2Anti-Feline EXOC3L1 monoclonal antibodyFeline
GM-Tg-cang-IP2481-Ab-1/ GM-Tg-cang-IP2481-Ab-2Anti-Canine EXOC3L1 monoclonal antibodyCanine
GM-Tg-bovg-IP2481-Ab-1/ GM-Tg-bovg-IP2481-Ab-2Anti-Bovine EXOC3L1 monoclonal antibodyBovine
GM-Tg-equg-IP2481-Ab-1/ GM-Tg-equg-IP2481-Ab-2Anti-Equine EXOC3L1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2481-Ab-1/ GM-Tg-hg-IP2481-Ab-2; GM-Tg-rg-IP2481-Ab-1/ GM-Tg-rg-IP2481-Ab-2;
GM-Tg-mg-IP2481-Ab-1/ GM-Tg-mg-IP2481-Ab-2; GM-Tg-cynog-IP2481-Ab-1/ GM-Tg-cynog-IP2481-Ab-2;
GM-Tg-felg-IP2481-Ab-1/ GM-Tg-felg-IP2481-Ab-2; GM-Tg-cang-IP2481-Ab-1/ GM-Tg-cang-IP2481-Ab-2;
GM-Tg-bovg-IP2481-Ab-1/ GM-Tg-bovg-IP2481-Ab-2; GM-Tg-equg-IP2481-Ab-1/ GM-Tg-equg-IP2481-Ab-2
Products NameAnti-EXOC3L1 monoclonal antibody
Formatmab
Target NameEXOC3L1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EXOC3L1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2481-Ag-1Recombinant multi-species EX3L1/ EXOC3L1/ EXOC3L protein


    Target information

    Target IDGM-IP2481
    Target NameEXOC3L1
    Gene ID283849,277978,291961,696499,526306,100053074
    Gene Symbol and SynonymsC730015A04Rik,EXOC3L,EXOC3L1,KIAA0895L,RGD1311132
    Uniprot AccessionQ86VI1,Q0VCR8
    Uniprot Entry NameEX3L1_HUMAN,EX3L1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179044
    Target ClassificationN/A

    The target: EXOC3L1, gene name: EXOC3L1, also named as EXOC3L. Predicted to enable SNARE binding activity. Predicted to be involved in exocyst localization; exocytosis; and peptide hormone secretion. Predicted to be located in secretory granule. Predicted to be part of exocyst. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.